J-147 Powder stands as a dedicated research product, explicitly formulated for scientific exploration and devoid of any implication of human consumption. This powdered form of J-147 offers researchers a valuable tool to investigate its unique properties and potential benefits in various research domains.
J-147, recognized for its distinct pharmacological profile, is a derivative of curcumin and cyclohexyl-bisphenol A. It has garnered attention for its potential neuroprotective and cognitive-enhancing properties, making it a subject of interest in neuroscience and related fields.
J-147 Powder finds versatile applications in research domains, providing researchers with a tool to explore its potential benefits, with a specific focus on Alzheimer’s disease, nootropic effects, and mitochondrial function improvement.
J-147 and Alzheimer’s disease
Studies indicate that J-147 may have potential neuroprotective effects against Alzheimer’s disease. Research in this domain aims to uncover its mechanisms of action and therapeutic potential in addressing neurodegenerative conditions.
J-147 is a Potential Nootropic
Preliminary research suggests that J-147 may exhibit nootropic properties, potentially influencing cognitive function. Investigations into its impact on memory, learning, and overall cognitive enhancement contribute to understanding its potential as a nootropic compound.
J147 May Improve Mitochondrial Function
Research indicates that J-147 may have a role in improving mitochondrial function. Studies exploring its effects on cellular energy production contribute to our understanding of its potential applications in promoting mitochondrial health.
J-147 Powder, meticulously crafted for research purposes, offers researchers an opportunity to explore its potential benefits in Alzheimer’s disease, as a potential nootropic, and in improving mitochondrial function. The distinct characteristics of J-147 make it a promising subject for further exploration in neuroscientific and cognitive research.
- Prior M, Dargusch R, Ehren JL, Chiruta C, Schubert D. The neurotrophic compound J147 reverses cognitive impairment in aged Alzheimer’s disease mice. Alzheimers Res Ther. 2013 May 14;5(3):25. doi: 10.1186/alzrt179. PMID: 23673233; PMCID: PMC3706879. [Read More]
- Prior M, Dargusch R, Ehren JL, Chiruta C, Schubert D. The neurotrophic compound J147 reverses cognitive impairment in aged Alzheimer’s disease mice. Alzheimers Res Ther. 2013 May 14;5(3):25. doi: 10.1186/alzrt179. PMID: 23673233; PMCID: PMC3706879. [Read More].
- 2009). The molecular composition of the mitochondrial transition pore. Journal of Molecular Cell Cardiology, 46(6), 850–857. https://doi.org/10.1016/j.micinf.2011.07.011.Inna [Read More]. (